Literature DB >> 32065881

Manipulation of microbiota with probiotics as an alternative for treatment of hepatic encephalopathy.

Renata Rivera-Flores1, Segundo Morán-Villota2, Luisa Cervantes-Barragán3, Constantino López-Macias4, Misael Uribe5.   

Abstract

Hepatic encephalopathy is a cerebral alteration mainly caused by hepatic insufficiency or portosystemic shunt. It ranges from minimal neurologic manifestations to coma in its overt stage. The multifactorial pathophysiology of hepatic encephalopathy has rendered numerous treatment alternatives, among which the modification of dysbiosis and hyperammonemia are currently considered to be effective, not only clinically, but also regarding cost. Recent work has developed knowledge of probiotics in different clinical settings including the relationship of the gut microenvironment to liver cirrhosis. The aim of this review was to analyze the results of clinical trials on the effect of different probiotics on hepatic encephalopathy.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Hepatic encephalopathy; Microbiota; Probiotic

Mesh:

Year:  2019        PMID: 32065881     DOI: 10.1016/j.nut.2019.110693

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  3 in total

1.  Differences in faecal microbiome composition between adult patients with UCD and PKU and healthy control subjects.

Authors:  C Timmer; M Davids; M Nieuwdorp; J H M Levels; J G Langendonk; M Breederveld; N Ahmadi Mozafari; M Langeveld
Journal:  Mol Genet Metab Rep       Date:  2021-09-08

Review 2.  Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.

Authors:  Jiachen Liu; Yantao Xu; Bimei Jiang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-22       Impact factor: 5.293

3.  Retention enema with traditional Chinese medicine for hepatic encephalopathy: A protocol for a systematic review and meta-analysis.

Authors:  Xiao Liang; Lihong Wen; Yifang Wu; Yanmin Hao; Shaobo Wang; Xiaoyu Hu
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.